These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20160743)

  • 1. Biosimilars: evidential standards for health technology assessment.
    Hughes DA
    Clin Pharmacol Ther; 2010 Mar; 87(3):257-61. PubMed ID: 20160743
    [No Abstract]   [Full Text] [Related]  

  • 2. Perspectives on "early dialogue" between a manufacturer and health technology assessment agencies.
    Geisler BP
    Value Health; 2011 Jun; 14(4):607. PubMed ID: 21669386
    [No Abstract]   [Full Text] [Related]  

  • 3. Health technology assessment (HTA) increasingly important in spine research.
    van Tulder M
    Eur Spine J; 2011 Jul; 20(7):999-1000. PubMed ID: 21720729
    [No Abstract]   [Full Text] [Related]  

  • 4. The need for Health Technology Assessments of PET.
    Van Tinteren H; Hoekstra OS; Boers M
    Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1438-9; author reply 1439. PubMed ID: 12898206
    [No Abstract]   [Full Text] [Related]  

  • 5. Health technology assessment of PET in oncology: re Eur J Nucl Med Mol Imaging 2003; 30:637-641.
    Kristensen FB; Adams E; Briones E; Coburn D; Facey K; Hansen NW; Hoeksema J; Mørland B
    Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):295-7; author reply 297-8; discussion 298. PubMed ID: 15129712
    [No Abstract]   [Full Text] [Related]  

  • 6. Are health technology assessments a reliable tool in th analysis of the clinical value of PET in oncology? Who audits the auditors?
    Højgaard L
    Eur J Nucl Med Mol Imaging; 2003 May; 30(5):637-41. PubMed ID: 12838956
    [No Abstract]   [Full Text] [Related]  

  • 7. Health technology assessment in Europe.
    Kristensen FB
    Scand J Public Health; 2009 Jun; 37(4):335-9. PubMed ID: 19493989
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug delivery system innovation and Health Technology Assessment: Upgrading from Clinical to Technological Assessment.
    Panzitta M; Bruno G; Giovagnoli S; Mendicino FR; Ricci M
    Int J Pharm; 2015 Nov; 495(2):1005-18. PubMed ID: 26399633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Setting the research agenda for women and children: the role of Health Technology Assessment.
    Choonara I; Kenny T
    Arch Dis Child; 2013 Aug; 98(8):574-5. PubMed ID: 23749947
    [No Abstract]   [Full Text] [Related]  

  • 10. AAMI Standards: A History of Ensuring Medical Technology Quality and Performance.
    Lewelling J
    Biomed Instrum Technol; 2017; 51(3):210-211. PubMed ID: 28530882
    [No Abstract]   [Full Text] [Related]  

  • 11. Why rankings of biomedical image analysis competitions should be interpreted with care.
    Maier-Hein L; Eisenmann M; Reinke A; Onogur S; Stankovic M; Scholz P; Arbel T; Bogunovic H; Bradley AP; Carass A; Feldmann C; Frangi AF; Full PM; van Ginneken B; Hanbury A; Honauer K; Kozubek M; Landman BA; März K; Maier O; Maier-Hein K; Menze BH; Müller H; Neher PF; Niessen W; Rajpoot N; Sharp GC; Sirinukunwattana K; Speidel S; Stock C; Stoyanov D; Taha AA; van der Sommen F; Wang CW; Weber MA; Zheng G; Jannin P; Kopp-Schneider A
    Nat Commun; 2018 Dec; 9(1):5217. PubMed ID: 30523263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The critical role of research evidence in the framework of health technology assessment].
    Sauerland S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):251-6. PubMed ID: 16477456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From false-positives to technological Darwinism: controversies in digital health.
    Bhavnani SP; Harzand A
    Per Med; 2018 Jul; 15(4):247-250. PubMed ID: 29931996
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapid response in health technology assessment: a Delphi study for a Brazilian guideline.
    Silva MT; Silva END; Barreto JOM
    BMC Med Res Methodol; 2018 Jun; 18(1):51. PubMed ID: 29884121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Innovation in health care: the role of HTA in the introduction of new technologies].
    Bührlen B
    Z Evid Fortbild Qual Gesundhwes; 2010; 104(10):703-8. PubMed ID: 21147431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward a sustainable European Network for Health Technology Assessment. The EUnetHTA project.
    Kristensen FB; Chamova J; Hansen NW
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):283-5. PubMed ID: 16453137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value judgements in the analysis of evidence: largely non-transparent, frequently contentious and never avoidable].
    Strech D
    Z Evid Fortbild Qual Gesundhwes; 2010; 104(3):168-76. PubMed ID: 20608243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NICE Health Technology Appraisal Programme.
    Burchell M; Ruiz F; Barnett D
    Ann R Coll Surg Engl; 2005 Jul; 87(4):283-4. PubMed ID: 16884603
    [No Abstract]   [Full Text] [Related]  

  • 19. Guidelines for evidence synthesis reporting: medications.
    Frutos Pérez-Surio A; Jordán de Luna C
    Eur J Hosp Pharm; 2020 Sep; 27(5):306-309. PubMed ID: 32839265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weighing of Evidence by Health Technology Assessment Bodies: Retrospective Study of Reimbursement Recommendations for Conditionally Approved Drugs.
    Vreman RA; Bouvy JC; Bloem LT; Hövels AM; Mantel-Teeuwisse AK; Leufkens HGM; Goettsch WG
    Clin Pharmacol Ther; 2019 Mar; 105(3):684-691. PubMed ID: 30300938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.